ESG Trends in Pharmaceutical Industry
Report Scope:
The report will provide an outline of the global pharmaceutical industry and an ESG overview of the pharmaceutical industry. Qualitative insights on ESG trends and their impact on pharmaceutical manufacturers are provided, along with a detailed analysis of the pharmaceutical industry supply chain with regard to ESG. The report explains the primary drivers, challenges and trends influencing ESG implementation in the pharmaceutical industry.
Report Includes:
A brief general outlook of the ESG trends in pharmaceutical industry
Detailed information about ESG-related developments in the pharmaceutical industry and analyses of factors affecting ESG applications
Discussion of current trends and issues in the pharmaceutical industry, with emphasis on major challenges and opportunities
Analysis of the whole supply chain of the pharmaceutical industry and its association with ESG
Information on major causes, and impact of pharmaceutical pollution and a detailed case study related to pharmaceutical pollution
- Chapter 1 Introduction
- 1.1 What is Environmental, Social and Governance (ESG) Compliance?
- 1.2 Study Goals and Objectives
- 1.3 Reasons for Doing This Study
- 1.4 Scope of Report
- 1.5 Intended Audience
- 1.6 Information Sources
- 1.7 Analyst's Credentials
- 1.8 BCC Custom Research
- 1.9 Related BCC Research Reports
- Chapter 2 Overview of the Pharmaceutical Industry
- 2.1 Introduction
- 2.2 Pharmaceutical Industry Supply Chain
- 2.2.1 Manufacturing
- 2.2.2 Distribution
- 2.2.3 Providers
- 2.2.4 Customers and Patients
- 2.3 ESG Deterrents in the Pharmaceutical Supply Chain
- Chapter 3 Environmental Impact of the Pharmaceutical Industry
- 3.1 Introduction
- 3.2 Major Causes of Pharmaceutical Pollution
- 3.2.1 Drug Use, Ingestion and Disposal
- 3.2.2 Healthcare Institutions
- 3.2.3 Drug Manufacturers
- 3.2.4 Agriculture and Argo-Products
- 3.2.5 Local Pharmaceutical Use and Disposal in Humans
- 3.3 Impact of Pharmaceutical Pollution
- 3.3.1 Effects on Aquatic Life and Fish
- 3.3.2 Disrupting Normal Sewerage Process Operations
- 3.3.3 Drinking Water Impact
- 3.3.4 Long-Lasting Effects on the Environment
- 3.3.5 Antibiotic Resistance
- 3.3.6 Impact on Wildlife
- 3.4 Growing Focus on Scope 3 Emissions
- 3.4.1 Case Study on Pharmaceutical Pollution
- Chapter 4 ESG in the Pharmaceutical Industry
- 4.1 Introduction to ESG
- 4.2 Increasing Adoption of ESG across Various Industries
- 4.3 ESG Proposition in Five Critical Ways
- 4.4 ESG Performance in the Pharmaceutical Industry
- 4.5 Surge in Investment in ESG in the Pharmaceutical Industry
- 4.6 ESG Investments by Key Players
- 4.7 Companies Incorporating ESG into Their Value Chains
- 4.7.1 Biogen
- 4.7.2 Collaboration between Novartis and GSK in Africa
- 4.7.3 Amgen
- 4.7.4 Enabler
- Chapter 5 Market Dynamics
- 5.1 Macroeconomic Trends in the Market for ESG in the Pharmaceutical Industry
- 5.1.1 Climate Change
- 5.1.2 Medication Access in Underdeveloped Nations
- 5.1.3 Drug Pricing and Gouging
- 5.2 ESG-Related Drivers of the Pharmaceutical Industry
- 5.3 ESG-Related Challenges for Pharmaceutical Industry
- 5.4 ESG-Related Opportunities in the Pharmaceutical Industry
- Chapter 6 Appendix: Acronyms
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook